Advertisement

Immunology of Keratoplasty

  • Daniel BöhringerEmail author
  • Thomas Reinhard
Chapter

Abstract

This is an overview of the current understanding of the pathomechanisms in graft rejection after keratoplasty. We discuss the experimental data on allorecognition and ACAID. We cover tissue typing of the human leukocyte antigen system and selected minor antigens. We give an overview of the clinical evidence in this field. The chapter ends with a recommendation on the best clinical practices with respect to tissue typing in keratoplasty.

Keywords

ACAID Immune reaction Allorecognition HLA MHC Matching HLAMatchmaker Antibody Minor antigens Histocompatibility 

References

  1. 1.
    Anshu A, Price MO, Price FWJ. Risk of corneal transplant rejection significantly reduced with descemet’s membrane endothelial keratoplasty. Ophthalmology. 2012;119(3):536–40. doi: 10.1016/j.ophtha.2011.09.019.CrossRefPubMedGoogle Scholar
  2. 2.
    Archbold JK, Ely LK, Kjer-Nielsen L, Burrows SR, Rossjohn J, McCluskey J, Macdonald WA. T cell allorecognition and MHC restriction – a case of Jekyll and Hyde? Mol Immunol. 2008;45(3):583–98. doi: 10.1016/j.molimm.2006.05.018.CrossRefPubMedGoogle Scholar
  3. 3.
    Ardjomand N, Komericki P, Klein A, Mattes D, El-Shabrawi Y, Radner H. ABO blood group expression in corneal allograft failures. Ophthalmologe. 2005;102(10):981–6. doi: 10.1007/s00347-005-1199-1.CrossRefPubMedGoogle Scholar
  4. 4.
    Ardjomand N, Komericki P, Radner H, Aigner R, Reich ME. Bedeutung der gewebslagerzeit f¨ur den erfolg nach kornealer transplantation. Ophthalmologe. 1997;94(10):703–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Baggesen K, Lamm LU, Ehlers N. Significant effect of high-resolution HLA-DRB1 matching in high-risk corneal transplantation. Transplantation. 1996;62(9):1273–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Bartels MC, Doxiadis IIN, Colen TP, Beekhuis WH. Long-term outcome in high-risk corneal transplantation and the influence of HLA-A and HLA-B matching. Cornea. 2003;22(6):552–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Baumler M, Sundmacher L, Reinhard T, Bohringer D. Cost-effectiveness of human leukocyte antigen matching in penetrating keratoplasty. Int J Technol Assess Health Care. 2014;30:1–9. doi: 10.1017/S0266462313000603.
  8. 8.
    Böhringer D, Daub F, Schwartzkopff J, Maier P, Birnbaum F, Sundmacher R, Reinhard T. Operational post-keratoplasty graft tolerance due to differential HLAMatchmaker matching. Mol Vis. 2010;16:2362–7.PubMedCentralPubMedGoogle Scholar
  9. 9.
    Böhringer D, Reinhard T, Böhringer S, Enczmann J, Godehard E, Sundmacher R. Predicting time on the waiting list for HLA matched corneal grafts. Tissue Antigens. 2002;59(0001–2815 (Print)):407–11.CrossRefPubMedGoogle Scholar
  10. 10.
    Böhringer D, Spierings E, Enczmann J, Bohringer S, Sundmacher R, Goulmy E, Reinhard T. Matching of the minor histocompatibility antigen HLA-A1/H-Y may improve prognosis in corneal transplantation. Transplantation. 2006;82(8):1037–41. doi: 10.1097/01.tp.0000235908.54766.44.CrossRefPubMedGoogle Scholar
  11. 11.
    Boisjoly HM, Roy R, Bernard PM, Dube I, Laughrea PA, Bazin R. Association between corneal allograft reactions and HLA compatibility. Ophthalmology. 1990;97(12):1689–98.CrossRefPubMedGoogle Scholar
  12. 12.
    Borderie VM, Lopez M, Vedie F, Laroche L. Abo antigen blood-group compatibility in corneal transplantation. Cornea. 1997;16(1):1–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Coster DJ, Jessup CF, Williams KA. Mechanisms of corneal allograft rejection and regional immunosuppression. Eye (Lond). 2009;23(10):1894–7. doi: 10.1038/eye.2009.17.CrossRefGoogle Scholar
  14. 14.
    Cunnusamy K, Paunicka K, Reyes N, Yang W, Chen PW, Niederkorn JY. Two different regulatory T cell populations that promote corneal allograft survival. Invest Ophthalmol Vis Sci. 2010;51(12):6566–74. doi: 10.1167/iovs.10-6161.PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Des Marchais B, Bazin R, Boisjoly HM, Laughrea PA, Dube I, Lille S, Roy R. Role of presensitization and donor-recipient crossmatching in corneal graft outcome. Cornea. 1998;17(2):141–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Duquesnoy RJ. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol. 2002;63(5):339–52.CrossRefPubMedGoogle Scholar
  17. 17.
    Goulmy E, Pool J, Van Lochem E, Volker-Dieben H. The role of human minor histocompatibility antigens in graft failure: a mini-review. Eye. 1995;9((Pt 2) (0950-222X (Print))):180–4.CrossRefPubMedGoogle Scholar
  18. 18.
    Hoffmann F, Tregel M, Noske W, Bunte S. HLA-B and -DR match reduces the allograft reaction after keratoplasty. Ger J Ophthalmol. 1994;3(2):100–4.PubMedGoogle Scholar
  19. 19.
    Hoffmann F, von Keyserlingk HJ, Wiederholt M. Importance of HLA DR matching for corneal transplantation in high-risk cases. Cornea. 1986;5(3):139–43.CrossRefPubMedGoogle Scholar
  20. 20.
    Hopkins KA, Maguire MG, Fink NE, Bias WB. Reproducibility of HLA-A, B, and DR typing using peripheral blood samples: results of retyping in the collaborative corneal transplantation studies. Collaborative corneal transplantation studies group (corrected). Hum Immunol. 1992;33(2):122–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Illigens BM, Yamada A, Fedoseyeva EV, Anosova N, Boisgerault F, Valujskikh A, Heeger PS, Sayegh MH, Boehm B, Benichou G. The relative contribution of direct and indirect antigen recognition pathways to the alloresponse and graft rejection depends upon the nature of the transplant. Hum Immunol. 2002;63(10):912–25.CrossRefPubMedGoogle Scholar
  22. 22.
    Inoue K, Amano S, Oshika T, Tsuru T. Histocompatibility Y antigen compatibility and allograft rejection in corneal transplantation. Eye. 2000;14((Pt 2) (0950-222X (Print))):201–5.CrossRefPubMedGoogle Scholar
  23. 23.
    Inoue K, Tsuru T. ABO antigen blood-group compatibility and allograft rejection in corneal transplantation. Acta Ophthalmol Scand. 1999;77(5):495–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Khaireddin R, Wachtlin J, Hopfenmuller W, Hoffmann F. HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection. Graefes Arch Clin Exp Ophthalmol. 2003;241(12):1020–8. doi: 10.1007/s00417-003-0759-9.CrossRefPubMedGoogle Scholar
  25. 25.
    Klein J, Figueroa F, Nagy ZA. Genetics of the major histocompatibility complex: the final act. Annu Rev Immunol. 1983;1:119–42. doi: 10.1146/annurev.iy.01.040183.001003.CrossRefPubMedGoogle Scholar
  26. 26.
    Marsh SGE. Nomenclature for factors of the HLA system, update march 2014. Int J Immunogenet. 2014;41(4):351–60. doi: 10.1111/iji.12125.CrossRefGoogle Scholar
  27. 27.
    Mayer WJ, Irschick UM, Moser P, Wurm M, Huemer HP, Romani N, Irschick EU. Characterization of antigen-presenting cells in fresh and cultured human corneas using novel dendritic cell markers. Invest Ophthalmol Vis Sci. 2007;48(10):4459–67. doi: 10.1167/iovs.06-1184.CrossRefPubMedGoogle Scholar
  28. 28.
    Munkhbat B, Hagihara M, Sato T, Tsuchida F, Sato K, Shimazaki J, Tsubota K, Tsuji K. Association between HLA-DPB1 matching and 1-year rejection-free graft survival in high-risk corneal transplantation. Transplantation. 1997;63(7):1011–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Niederkorn JY. The induction of anterior chamber-associated immune deviation. Chem Immunol Allergy. 2007;92:27–35. doi: 10.1159/000099251.CrossRefPubMedGoogle Scholar
  30. 30.
    Reinhard T, Bocking A, Pomjanski N, Sundmacher R. Immune cells in the anterior chamber of patients with immune reactions after penetrating keratoplasty. Cornea. 2002;21(1):56–61.CrossRefPubMedGoogle Scholar
  31. 31.
    Reinhard T, Böhringer D, Enczmann J, Kogler G, Mayweg S, Wernet P, Sundmacher R. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching. Eye. 2004;18(0950-222X (Print)):269–77.CrossRefPubMedGoogle Scholar
  32. 32.
    Reinhard T, Spelsberg H, Henke L, Kontopoulos T, Enczmann J, Wernet P, Berschick P, Sundmacher R, Böhringer D. Long-term results of allogeneic penetrating limbokeratoplasty in total limbal stem cell deficiency. Ophthalmology. 2004;111(0161–6420 (Print)):775–82.CrossRefPubMedGoogle Scholar
  33. 33.
    Roy R, Des Marchais B, Bazin R, Boisjoly HM, Dube I, Laughrea PA. Role of ABO and lewis blood group antigens in donor-recipient compatibility of corneal transplantation rejection. Ophthalmology. 1997;104(3):508–12.CrossRefPubMedGoogle Scholar
  34. 34.
    Sarkar RS, Philip J, Yadav P. Transfusion medicine and solid organ transplant – update and review of some current issues. Med J Armed Forces India. 2013;69(2):162–7. doi: 10.1016/j.mjafi.2012.11.012.PubMedCentralCrossRefPubMedGoogle Scholar
  35. 35.
    Sel S, Schlaf G, Schurat O, Altermann WW. A novel ELISA-based crossmatch procedure to detect donor-specific anti-HLA antibodies responsible for corneal allograft rejections. J Immunol Methods. 2012;381(1–2):23–31. doi: 10.1016/j.jim.2012.04.005.CrossRefPubMedGoogle Scholar
  36. 36.
    Simon M, Fellner P, El-Shabrawi Y, Ardjomand N. Influence of donor storage time on corneal allograft survival. Ophthalmology. 2004;111(8):1534–8. doi: 10.1016/j.ophtha.2003.12.060. Immunology of keratoplasty 11.CrossRefPubMedGoogle Scholar
  37. 37.
    Streilein JW, Arancibia-Caracamo C, Osawa H. The role of minor histocompatibility alloantigens in penetrating keratoplasty. Dev Ophthalmol. 2003;36:74–88.CrossRefPubMedGoogle Scholar
  38. 38.
    The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The collaborative corneal transplantation studies research group. Arch Ophthalmol. 1992;110(10):1392–403.CrossRefGoogle Scholar
  39. 39.
    Vail A, Gore SM, Bradley BA, Easty DL, Rogers CA, Armitage WJ. Conclusions of the corneal transplant follow up study. Collaborating surgeons. Br J Ophthalmol. 1997;81(8):631–6.PubMedCentralCrossRefPubMedGoogle Scholar
  40. 40.
    Völker-Dieben HJ, Claas FH, Schreuder GM, Schipper RF, Pels E, Persijn GG, Smits J, D’Amaro J. Beneficial effect of HLA-DR matching on the survival of corneal allografts. Transplantation. 2000;70(4):640–8.CrossRefPubMedGoogle Scholar
  41. 41.
    Yamada J, Streilein JW. Fate of orthotopic corneal allografts in C57bL/6 mice. Transpl Immunol. 1998;6(3):161–8.CrossRefPubMedGoogle Scholar
  42. 42.
    Yamagami S, Dana MR, Tsuru T. Draining lymph nodes play an essential role in alloimmunity generated in response to high-risk corneal transplantation. Cornea. 2002;21(4):405–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Eye CenterUniversity Hospital FreiburgFreiburgGermany

Personalised recommendations